Third Harmonic Bio Inc. Conducted Annual Stockholders Meeting

Reuters06-12
Third Harmonic Bio Inc. Conducted Annual Stockholders Meeting

Third Harmonic Bio Inc. held its 2025 Annual Meeting of Stockholders on June 5, 2025. During the meeting, several proposals were adopted. The election of three Class III directors, Thomas M. Soloway, David Bonita, M.D., and Goeff McDonough, M.D., was approved. The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. The liquidation and dissolution of the Company, in accordance with the Plan of Dissolution, was approved. Additionally, the proposal to grant discretionary authority to the Board to adjourn the meeting to solicit additional proxies if needed was approved.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Third Harmonic Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-139141), on June 11, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment